Tregalizumab
N/A
Report date: 2022/07/04 19:38:02
Base Information
Drug NameTregalizumab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[17]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiotest Pharma Gmbh
China Registration ClassN/A
Develop Information
Active CompaniesT-Balance Therapeutics GmbH
Inactive CompaniesBiotest Ag
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksWikipedia